Cormorant Asset Management, LP Genetron Holdings LTD Transaction History

Cormorant Asset Management, LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$11.55 - $20.3 $1.53 Million - $2.7 Million	-132,867 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$17.9 - $23.29 $2.99 Million - $3.89 Million	-167,133 Reduced 55.71%	132,867 $2.68 Million
Q1 2021 May 17, 2021	SELL	$13.71 - $30.64 $1.37 Million - $3.06 Million	-100,000 Reduced 25.0%	300,000 $6.44 Million
Q4 2020 Feb 16, 2021	SELL	$9.31 - $14.0 $931,000 - $1.4 Million	-100,000 Reduced 20.0%	400,000 $5.6 Million
Q2 2020 Aug 14, 2020	BUY	$11.29 - $16.0 $5.65 Million - $8 Million	500,000 New	500,000 $6.04 Million

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

Stay updated on Cormorant Asset Management, LP with notifications on news.